α-Casein (90-95)

CAT:
804-HY-P1793-01
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
α-Casein (90-95) - image 1

α-Casein (90-95)

  • Description:

    α-Casein (90-95) is a partial agonist of opioid receptors and a copper ion ligand, with opioid activity. α-Casein (90-95) inhibits the secretion of β-hexosaminidase by rat peritoneal mast cells (PMC) with IC50= 0.1 μM. α-Casein (90-95) inhibits the proliferation of prostate cancer cells LNCaP, DU145, and PC3 with IC50 of 0.94 nM, 137 nM, and 6.92 nM, respectively. α-Casein (90-95) activates Gi-like proteins through a membrane-assisted, receptor-independent pathway, or reversibly binds to opioid receptors, inducing intracellular calcium release and conformational changes, and exerts the activity of promoting mast cell secretion and inhibiting tumor cell proliferation. α-Casein (90-95) can be used in the study of the mechanisms of allergic diseases and prostate cancer[1][2][3].
  • UNSPSC:

    12352209
  • Target:

    Biochemical Assay Reagents; Opioid Receptor
  • Type:

    Peptides
  • Related Pathways:

    GPCR/G Protein; Neuronal Signaling; Others
  • Applications:

    Neuroscience-Neuromodulation
  • Field of Research:

    Cancer; Inflammation/Immunology; Neurological Disease
  • Assay Protocol:

    https://www.medchemexpress.com/alpha-casein-90-95.html
  • Purity:

    99.51
  • Solubility:

    H2O
  • Smiles:

    O=C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H](CC(C)C)C(NCC(N[C@@H](CC2=CC=C(C=C2)O)C(N[C@@H](CC(C)C)C(O)=O)=O)=O)=O)=O)[C@H](CCCNC(N)=N)N
  • Molecular Formula:

    C38H57N9O9
  • Molecular Weight:

    783.91
  • References & Citations:

    [1]Chruścińska E, et al. Binding ability of Cu2+ ions by opiate-like fragments of bovine casein. J Inorg Biochem. 1997 Apr;66 (1) :19-22.|[2]Stępnik M, et al. The influence of bovine casein-derived exorphins on mast cells in rodents[J]. Revue française d'allergologie et d'immunologie clinique, 2002, 42 (5) : 447-453.|[3]Kampa M, et al. Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors. Eur J Pharmacol. 1997 Sep 24;335 (2-3) :255-65.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
  • Scientific Category:

    Peptides
  • Clinical Information:

    No Development Reported
  • CAS Number:

    83471-50-5